Glycosylation is a frequent co/post-translational modification of proteins which modulates a variety of biological functions. The analysis of N-glycome, i.e. the sugar chains N-linked to asparagine, identified new candidate biomarkers of aging such as N-glycans devoid of galactose residues on their branches, in a variety of human and experimental model systems, such as healthy old people, centenarians and their offspring and caloric restricted mice. These agalactosylated biantennary structures mainly decorate Asn297 of Fc portion of IgG (IgG-G0), and are present also in patients affected by progeroid syndromes and a variety of autoimmune/inflammatory diseases. IgG-G0 exert a pro-inflammatory effect through different mechanisms, including the lectin pathway of complement, binding to Fc␥ receptors and formation of autoantibody aggregates. The age-related accumulation of IgG-G0 can contribute to inflammaging, the low-grade pro-inflammatory status that characterizes elderly, by creating a vicious loop in which inflammation is responsible for the production of aberrantly glycosylated IgG which, in turn, would activate the immune system, exacerbating inflammation. Moreover, recent data suggest that the N-glycomic shift observed in aging could be related not only to inflammation but also to alteration of important metabolic pathways. Thus, altered N-glycans are both powerful markers of aging and possible contributors to its pathogenesis.
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Introduction
Enzymatic glycosylation (not to be confused with nonenzymatic glycosylation, referred to as glycation) represents one of the most frequently occurring co/postranslational modification of proteins. A significant percentage of the human genes encode proteins related with biosynthesis, function and degradation of sugar chains. Protein-linked sugar chains play a variety of highly specific roles, acting as a "fine tuning" of the interactions between cells and between molecules (Hart and Copeland, 2010; Ohtsubo and Marth, 2006; Varki, 1993) . A brief summary of some biological functions played by the glycans of glycoproteins is reported in Table 1 . The sugar chains linked to glycoproteins are classified mainly as N-linked chains, which are bound to the amidic nitrogen of asparagine, and O-linked chains which are bound to the hydroxyl group of serine or threonine. Glycosylation undergoes profound changes in a variety of pathological conditions, including cancer [reviewed in Dall'Olio et al., 2012a,b] , inflammatory and autoimmune diseases and in the pathophysiological process of aging. Recently developed high-throughput methods of analysis have allowed investigating the whole spectrum of N-linked glycans (N-glycome) present in serum and body fluids of a large number of individuals, revealing characteristic aging-associated N-glycome changes which are reminiscent of those associated with inflammatory and autoimmune diseases. These glycosylation changes appear to be associated particularly with the sugar chains linked to Asn297 of immunoglobulin G. In turn, these aberrantly glycosylated antibodies might be responsible for the activation and up-regulation of the inflammatory response through different, although ill defined, mechanisms. In this review, we will describe briefly the basic biosynthetic and structural aspects of N-glycosylation and the methods of N-glycome analysis. Then, we will discuss the most relevant N-glycans associated with aging and inflammatory
